Palma Sonia M M, Natale Ana Carolina M P, Calil Helena M
Department of Psychobiology, Universidade Federal de São Paulo (UNIFESP) , São Paulo , Brazil.
Universidade Mackenzie , São Paulo , Brazil.
Front Psychiatry. 2015 Oct 2;6:135. doi: 10.3389/fpsyt.2015.00135. eCollection 2015.
The aim of this study was to evaluate symptom persistence in attention-deficit/hyperactivity disorder (ADHD), the development of comorbidities, and psychostimulant usage patterns. Follow-up studies were conducted in 37 patients with ADHD and 22 healthy controls, aged 10 and 18, 4 years after their first assessment. The ADHD was rated as persistent if participants met all DSM-IV criteria for syndromic or sub-threshold persistence, or had functional impairments (functional persistence). Of the 37 ADHD patients we reevaluated, 75% had persistent symptoms, and psychiatric comorbidities with additional functional impairments and academic problems were more common than in controls. These follow-up findings show a high comorbidity associated with ADHD and support the importance of evaluation and treatment for ADHD and comorbidities throughout life.
本研究的目的是评估注意力缺陷多动障碍(ADHD)的症状持续性、共病的发展情况以及精神兴奋剂的使用模式。对37例ADHD患者和22名健康对照者进行了随访研究,这些患者和对照者年龄在10至18岁之间,首次评估4年后进行随访。如果参与者符合所有DSM-IV关于综合征或亚阈值持续性的标准,或存在功能损害(功能持续性),则将ADHD评定为持续性。在我们重新评估的37例ADHD患者中,75%有持续性症状,伴有额外功能损害和学业问题的精神共病比对照组更常见。这些随访结果表明ADHD与高共病率相关,并支持对ADHD及其共病进行终身评估和治疗的重要性。